PubMed · 42724828
Trastuzumab deruxtecan plus pertuzumab in first-line HER2-positive advanced/metastatic breast cancer.
Abstract
The source did not provide an abstract. Follow the original record for more information.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Sara M Tolaney, Sibylle Loibl. 2026-08-05. Trastuzumab deruxtecan plus pertuzumab in first-line HER2-positive advanced/metastatic breast cancer.. https://doi.org/10.21037/tcr-2026-1671
Cite the original work for its findings. Save a collection to share your selection of sources.